2013 Researcher Dr. Aru Narendran

A Virus to Kill by: Double-deleted Vaccinia virus (VVdd) as a novel therapeutic agent for a defiant pediatric brain tumour

Dr Aru Narendran
University of Calgary, Alberta Children’s Hospital, Calgary, AB
Award: $25,000

Dr. Narandran's project is funded through the generosity of the Pink Warrior Foundation, Saskatoon, SK


Project Summary:

Atypical teratoid rhabdoid tumour of the central nervous system (CNS AT/RT) is a highly malignant brain tumour of infancy that often causes death within months. In spite of multiple treatment regimens consisting of surgery, radiation and chemotherapy, with or without stem cell transplant, only a few long-term survivors of CNS AT/RT have been reported.

Hence, research is urgently needed to identify effective new agents and novel therapeutic approaches for these children. Recent studies have shown evidence for the use of oncolytic viruses (OVs) as a means to deliver effective cytotoxic therapy to tumors that have become resistant to conventional treatment approaches.

The idea behind this approach is to develop viruses that can replicate and cause the cancer cells to break down while leaving non-malignant cells unaffected. Vaccinia virus (VV) is a type of OV with several desirable attributes to be selected as a therapeutic agent, including a highly acceptable safety profile from its use as a vaccine in the small pox eradication program and its ability to positively alter specific immune responses. Based on our encouraging preliminary data, we propose to investigate the potential of a modified (double deleted) vaccinia virus in preclinical studies for the treatment of AT/RT.

Read more about Dr. Narendran in this story ...

“Your child has a brain tumour.” – Six shocking words no parent should ever have to hear, and the impact of which can be devastating. For Calgary researcher Dr. Aru Narendran, knowing first-hand what the brain tumour journey can mean for families motivates him to spend his days in a lab. There he and his team search for a cure for one of the most fatal types of malignant pediatric brain tumour, atypical teratoid/rhabdoid (AT/RT). Absolute in his determination to eradicate childhood cancers, Dr. Narendran has a few choice words of his own for the illness. “I don’t see a reason why we can’t cure every single kid with cancer. We cured polio and other diseases completely, so it’s just a matter of time. It will happen.” Read the rest of this story...

<back to 2013 Grant Awardees





Share This

Featured Story

Courtney’s Story of Stability

Stability. It’s a strange concept when you have what it known to be a progressive, life long illness. You hear the words, “Your tumour growth is stable” and for a moment you think someone is playing the world’s worst prank on you.

Learn more


Stephen's Story: "I have faith that we will meet again"

Stephen and I chatted on what should have been his 32nd Wedding Anniversary. Stephen and Susan were married for 30 years and were best...

Learn more

Tommy's Story: Fellowship recipient

Dr. Tommy Alain, the very first research Fellow funded by Brain Tumour Foundation of Canada through the William Donald Nash Brain...

Learn more

Upcoming Events

  • 23/Jan/2018: Groupe de soutien virtuel: Un groupe de soutien virtuel pour personnes touchées par une tumeur... Learn more >
  • 25/Jan/2018: Virtual Support Group East: Virtual Support Group for Eastern Canada... Learn more >
  • 25/Jan/2018: Sarnia Support Group: Meets at St. Giles Presbyterian Church,770 Lakeshore Road Sarnia, ON... Learn more >
  • 29/Jan/2018: Greater Sudbury Support Group: Meets at The Parkside Centre, 140 Durham Street, Sudbury, Ontario... Learn more >
View All Events >
Thank you to the donors whose contributions make this website and all programs, services and research possible.

Copyright © 2018 Brain Tumour Foundation of Canada. Charitable Registration #BN118816339RR0001
35 Years